Fig. 1From: TROP2 methylation and expression in tamoxifen-resistant breast cancer5-Aza-dC treatment decreases proliferation in the Tamoxifen-resistant cell line, TMX2-28. Proliferation, quantified by MTS assay, in control and 120-h 5-Aza-dC-treated cells. Data represented as percentage of control, for the parental line, MCF7, and the ERneg Tamoxifen-resistant cell line, TMX2-28 (n = 8, *p < 0.005)Back to article page